Legal status · Australia
Is Melanotan I legal in Australia?
Yes. Melanotan I is an approved medicine in Australia, classified as "TGA-registered for erythropoietic protoporphyria". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Melanotan I in Australia at a glance
| Classification | TGA-registered for erythropoietic protoporphyria |
|---|---|
| TGA approval status | Approved by TGA for its labeled use |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Melanotan I profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
TGA has approved Melanotan I for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Melanotan I is
An FDA-approved melanocortin agonist that increases skin pigmentation to protect people with a rare light-sensitivity disorder.
Melanotan I, or afamelanotide, is a melanocortin receptor agonist approved by the FDA in 2019 as Scenesse. It is used to increase pain-free light exposure in adults with erythropoietic protoporphyria, a rare inherited condition of severe skin light sensitivity, by stimulating protective pigmentation.
Mechanism: Agonizes the melanocortin-1 receptor to stimulate eumelanin production, increasing photoprotective skin pigmentation.
Regulatory history: FDA-approved (Scenesse) for erythropoietic protoporphyria
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Melanotan I at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Melanotan I in other countries
United States
Approved medicineFDA-approved for a specific indication, prescription only
Is Melanotan I legal in the United States?United Kingdom
Approved medicineLicensed (EU/UK) for erythropoietic protoporphyria
Is Melanotan I legal in the United Kingdom?Canada
Approved medicineApproved for erythropoietic protoporphyria
Is Melanotan I legal in Canada?Frequently asked questions
Is Melanotan I legal in Australia?
Yes. Melanotan I is an approved medicine in Australia, classified as "TGA-registered for erythropoietic protoporphyria". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Melanotan I in Australia?
Only with a prescription. Melanotan I is classified as "TGA-registered for erythropoietic protoporphyria" in Australia, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Melanotan I TGA approved?
Yes, for its labeled indication. In Australia Melanotan I is classified as "TGA-registered for erythropoietic protoporphyria". For comparison, the US FDA status is: FDA-approved (Scenesse) for erythropoietic protoporphyria. Evidence level: Strong.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Melanotan I live on its compound profile.
Melanotan I profileThis page is general information about the regulatory status of Melanotan I in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.